Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Manganese transport protein C (MntC) is a highly conserved, surface-exposed lipoprotein that serves as the substrate-binding component of the MntABC ATP-binding cassette (ABC) transporter system in Staphylococcus aureus and other staphylococcal species [1, 3, 8]. It facilitates the high-affinity acquisition of manganese from the host environment, which is an essential metal ion for bacterial survival and virulence during infection [1, 9]. Manganese acts as a vital cofactor for superoxide dismutase (SOD) enzymes, which protect the pathogen from reactive oxygen species (ROS) produced by host immune cells during the oxidative burst [3, 5, 8]. Beyond nutrient acquisition, MntC has been identified as a contributor to cell adhesion and colonization through its ability to bind host extracellular matrix proteins and plasminogen [6, 10]. Because it is expressed very early during the infectious cycle and is highly conserved across clinical isolates, MntC has been a primary target for the development of anti-staphylococcal vaccines [2, 4]. Therapeutic candidates, such as Pfizer’s four-antigen vaccine SA4Ag (PF-06290510), include recombinant MntC to elicit antibodies that interfere with manganese uptake and promote opsonophagocytic killing by host neutrophils [3, 11]. Despite showing robust protective efficacy in preclinical models, clinical advancement of MntC-targeting vaccines has been difficult. The Phase 2b/3 trial for SA4Ag was discontinued in 2018 due to a lack of efficacy in preventing invasive S. aureus infections in surgical patients, highlighting the complexity of targeting this pathogen [13, 15].
Vaccine antigen targeting bacterial nutrient acquisition and immune evasion; elicits antibodies that inhibit manganese uptake and promote opsonophagocytic killing by neutrophils.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Manganese transport protein C (MntC) (MntC).